Author:
Brookes K,Xu X,Chen W,Zhou K,Neale B,Lowe N,Aneey R,Franke B,Gill M,Ebstein R,Buitelaar J,Sham P,Campbell D,Knight J,Andreou P,Altink M,Arnold R,Boer F,Buschgens C,Butler L,Christiansen H,Feldman L,Fleischman K,Fliers E,Howe-Forbes R,Goldfarb A,Heise A,Gabriëls I,Korn-Lubetzki I,Marco R,Medad S,Minderaa R,Mulas F,Müller U,Mulligan A,Rabin K,Rommelse N,Sethna V,Sorohan J,Uebel H,Psychogiou L,Weeks A,Barrett R,Craig I,Banaschewski T,Sonuga-Barke E,Eisenberg J,Kuntsi J,Manor I,McGuffin P,Miranda A,Oades R D,Plomin R,Roeyers H,Rothenberger A,Sergeant J,Steinhausen H-C,Taylor E,Thompson M,Faraone S V,Asherson P,Johansson L
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference96 articles.
1. Asherson P . IMAGE consortium. Attention-deficit hyperactivity disorder in the post-genomic era. Eur Child Adolesc Psychiatry 2004; 13 (Suppl 1): 150–170.
2. Burd L, Klug MG, Coumbe MJ, Kerbeshian J . Children adolescents with attention deficit-hyperactivity disorder: 1. Prevalence cost of care. J Child Neurol 2003; 18: 555–561.
3. Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, Greenberg P et al. The prevalence effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med 2005; 47: 565–572.
4. Biederman J, Faraone SV . Attention-deficit hyperactivity disorder. Lancet 2005; 366: 237–248.
5. Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J et al. European clinical guidelines for hyperkinetic disorder – first upgrade. Eur Child Adolesc Psychiatry 2004; 13 (Suppl 1): 17–30.